Search Results - "lung cancer"

A Network Pharmacology Approach to Investigate the Anticancer Mechanism and Potential Active Ingredients of Rheum palmatum L. Against Lung Cancer via Induction of Apoptosis by Qing Zhang, Jia Liu, Ruolan Li, Rong Zhao, Mengmeng Zhang, Shujun Wei, Dong Ran, Wei Jin, Chunjie Wu

Connect to this object online.

Effect of zoledronic acid on tartrate-resistant acid phosphatase isoform type 5b and other bone markers in lung cancer patients with bone metastases by Zhang W, Rabinowits G, Laber DA, Kloecker GH

Connect to this object online.

Polyphenols in Ilex latifolia Thunb. inhibit human lung cancer cell line A549 by regulation of the PI3K-Akt signaling pathway by Jing Chen, Yesheng Du, Yanyan Long, Dan Tao, Mengyu Hu, Yong Jiang, Yue Wan, Dingyi Yang

Connect to this object online.

Small molecule purine and pseudopurine derivatives: synthesis, cytostatic evaluations and investigation of growth inhibitory effect in non-small cell lung cancer A549 by Andrea Bistrović, Petra Grbčić, Anja Harej, Mirela Sedić, Sandra Kraljević-Pavelić, Sanja Koštrun, Janez Plavec, Damjan Makuc, Silvana Raić-Malić

Connect to this object online.

nab-Paclitaxel/carboplatin in elderly patients with advanced squamous non-small cell lung cancer: a retrospective analysis of a Phase III trial by Gridelli C, Chen T, Ko A, O'Brien ME, Ong TJ, Socinski MA, Postmus PE

Connect to this object online.

The nomograms for predicting overall and cancer-specific survival in elderly patients with early-stage lung cancer: A population-based study using SEER database by Gen Yu, Xiaozhu Liu, Yunhe Li, Yang Zhang, Yang Zhang, Ruxin Yan, Lingfeng Zhu, Zhongjian Wang

Connect to this object online.

Circ-METTL15 contributes to the proliferation, metastasis, immune escape and restrains apoptosis in lung cancer by regulating miR-1299/PDL1 axis by Rui Zhang, Liang Shang, Jinniang Nan, Kai Niu, Jixin Dai, Xintian Jin, Xianghua Zhang

Connect to this object online.

Model‐based meta‐analysis of non‐small cell lung cancer with standard of care PD‐1 inhibitors and chemotherapy for early development decision making by David C. Turner, Russ Wada, Helen Zhou, Xiaowei Wang, Rik deGreef, Chandni Valiathan, Lindsey Zhang, Nancy Zhang, Mita Kuchimanchi, Tai‐Tsang Chen, Marc Ballas, Sandra A. G. Visser

Connect to this object online.

Tetrandrine activates STING/TBK1/IRF3 pathway to potentiate anti-PD-1 immunotherapy efficacy in non-small cell lung cancer by Yan Tan, Qiancheng Zhu, Meilin Yang, Fan Yang, Qi Zeng, Zebo Jiang, Dan Li

Connect to this object online.

Management of oligometastatic and oligoprogressive epidermal growth factor receptor mutated non-small cell lung cancer patients: state of the art of a combined approach by Francesca Di Pressa, Fabiana Perrone, Anna Benini, Frank Lohr, Marcello Tiseo, Alessio Bruni

Connect to this object online.

The survival and cost-effectiveness analysis of adjunctive Chinese medicine therapy for patients with non-small cell lung cancer: a nationwide cohort study in Taiwan by Meng-Bin Tang, Wei-Yin Kuo, Pei-Tseng Kung, Pei-Tseng Kung, Wen-Chen Tsai

Connect to this object online.

Burden of silica-attributed pneumoconiosis and tracheal, bronchus & lung cancer for global and countries in the national program for the elimination of silicosis, 1990-2019: a comparative study by Lingfeng Min, Yiyang Mao, Hanpeng Lai

Connect to this object online.

Obstructive sleep apnea promotes the progression of lung cancer by modulating cancer cell invasion and cancer-associated fibroblast activation via TGFβ signaling by Zhilei Cui, Zhengshang Ruan, Meigui Li, Rongrong Ren, Yizong Ma, Junxiang Zeng, Jinyuan Sun, Wenjing Ye, Weiguo Xu, Xuejun Guo, Dengfei Xu, Linlin Zhang

Connect to this object online.

Cost-effectiveness of first-line versus second-line use of brigatinib followed by lorlatinib in patients with ALK-positive non-small cell lung cancer by Wenjie Liu, Wenjie Liu, Wenjie Liu, Wenjie Liu, Gengwei Huo, Gengwei Huo, Gengwei Huo, Gengwei Huo, Peng Chen, Peng Chen, Peng Chen, Peng Chen

Connect to this object online.

PHARMACOECONOMIC EVALUATION OF THE MEDICINAL PRODUCTS ERLOTINIB, DOCETAXEL, PEMETREXED AND GEFITINIB IN THE SECOND-LINE TREATMENT OF LOCALLY-ADVANCED OR METASTATIC NON-SMALL-CELL LUNG CANCER by A. U. Kulikov

Connect to this object online.

Lung Cancer Screening Among U.S. Military Veterans by Health Status and Race and Ethnicity, 2017-2020: A Cross-Sectional Population-Based Study by Alison S. Rustagi, MD, PhD, Amy L. Byers, PhD, MPH, James K. Brown, MD, Natalie Purcell, PhD, Christopher G. Slatore, MD, MS, Salomeh Keyhani, MD, MPH

Connect to this object online.

Comparing efficacy and safety of upfront treatment strategies for anaplastic lymphoma kinase-positive non-small cell lung cancer: a network meta-analysis by Marco Filetti, Pasquale Lombardi, Rosa Falcone, Raffaele Giusti, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia, Gennaro Daniele

Connect to this object online.

The prevalence of Fibroblast Growth Factor Receptor 1 Gene (FGFR1) amplification in Non-Small Cell Lung Cancer (NSCLC) by Real-time PCR by Sanaz Homayounfar, Hossein Ayatollahi, Gordon Ferns, Reza Hemmatan Attarbashi, Masoumeh Gharib, Maryam Sheikhi, Zahra Khoshnegah, Payam Siyadat, Amirhossein Jafarian

Connect to this object online.

Toxic Epidermal Necrolysis and Stevens - Johnson Syndrome Following Sintilimab Administration in a Non-Small Cell Lung Cancer Patient: A Case Report by Jiang Z, Chen X, Sun Z, Shen X, Huang Y, Liu J

Connect to this object online.

Non-linear modifications enhance prediction of pathological response to pre-operative PD-1 blockade in lung cancer: A longitudinal hybrid radiological model by Weiqiu Jin, Yu Tian, Wendi Xuzhang, Hongda Zhu, Ningyuan Zou, Leilei Shen, Changzi Dong, Qisheng Yang, Long Jiang, Jia Huang, Zheng Yuan, Xiaodan Ye, Qingquan Luo

Connect to this object online.